Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$5.86bn	1021.46	n/a
CU6Clarity Pharmaceuticals	AU$1.47bn	n/a	n/a
MSBMesoblast	AU$1.01bn	n/a	n/a
PYCPYC Therapeutics	AU$447.94m	n/a	n/a
OPTOpthea	AU$416.10m	n/a	n/a
IMUImugene	AU$394.30m	n/a	n/a
IMMImmutep	AU$391.57m	n/a	n/a
RACRace Oncology	AU$297.56m	n/a	n/a
DXBDimerix	AU$225.87m	n/a	n/a
CGSCogstate	AU$191.93m	25.22	n/a
ACWActinogen Medical	AU$153.89m	n/a	n/a
ALAArovella Therapeutics	AU$127.35m	n/a	n/a
LTPLtr Pharma	AU$119.90m	n/a	n/a
PIQProteomics International Laboratories	AU$106.43m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$101.93m	n/a	n/a
AGNArgenica Therapeutics	AU$77.59m	n/a	n/a
PERPercheron Therapeutics	AU$72.12m	n/a	n/a
PEBPacific Edge	NZ$74.64m	n/a	n/a
NTINeurotech International	AU$63.31m	n/a	n/a
CYPCynata Therapeutics	AU$52.99m	n/a	n/a